Screening for Financial Toxicity in Clinical Care With Finance-Related Outcome Measures

Raymond Javan Chan; Louisa G. Gordon

doi:10.1097/NCC.0000000000000926

Screening for Financial Toxicity in Clinical Care With Finance-Related Outcome Measures

Raymond Javan Chan, Louisa G. Gordon

Research output: Contribution to journal › Editorial

8 Citations (Scopus)

Abstract

“Financial toxicity” (FT) describes both the objective financial burden and subjective financial distress from a cancer diagnosis and its treatment.^1,2 Up to 48% of cancer survivors report experiencing financial burden due to direct (eg, out-of-pocket expenses) and indirect (eg, loss of income) costs.³ Financial toxicity exists in all health systems including user-pay, universal, and hybrid settings.^3,4 Depending on a patient's individual circumstances, cancer diagnosis and treatments, and coping strategies,³ this burden may cause significant financial distress, reduced adherence with treatment, and delayed or forgone treatment, which lead to poorer health outcomes.^2,3,5 Our systematic review showed a 3-fold increased risk of depression and anxiety in cancer survivors experiencing FT.⁶ Individuals living in the most socioeconomically disadvantaged areas are at a greater risk of FT related to cancer care.⁷

Original language	English
Pages (from-to)	87-88
Number of pages	2
Journal	Cancer nursing
Volume	44
Issue number	2
DOIs	https://doi.org/10.1097/NCC.0000000000000926
Publication status	Published - Mar 2021
Externally published	Yes

Keywords

Financial Toxicity
Clinical Care
Outcome Measures

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/NCC.0000000000000926Licence: In Copyright

Cite this

@article{016e35e86fe64cc8be5eebcfefa03c49,

title = "Screening for Financial Toxicity in Clinical Care With Finance-Related Outcome Measures",

abstract = "“Financial toxicity” (FT) describes both the objective financial burden and subjective financial distress from a cancer diagnosis and its treatment.1,2 Up to 48% of cancer survivors report experiencing financial burden due to direct (eg, out-of-pocket expenses) and indirect (eg, loss of income) costs.3 Financial toxicity exists in all health systems including user-pay, universal, and hybrid settings.3,4 Depending on a patient's individual circumstances, cancer diagnosis and treatments, and coping strategies,3 this burden may cause significant financial distress, reduced adherence with treatment, and delayed or forgone treatment, which lead to poorer health outcomes.2,3,5 Our systematic review showed a 3-fold increased risk of depression and anxiety in cancer survivors experiencing FT.6 Individuals living in the most socioeconomically disadvantaged areas are at a greater risk of FT related to cancer care.7",

keywords = "Financial Toxicity, Clinical Care, Outcome Measures",

author = "Chan, {Raymond Javan} and Gordon, {Louisa G.}",

year = "2021",

month = mar,

doi = "10.1097/NCC.0000000000000926",

language = "English",

volume = "44",

pages = "87--88",

journal = "Cancer nursing",

issn = "0162-220X",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "2",

}

TY - JOUR

T1 - Screening for Financial Toxicity in Clinical Care With Finance-Related Outcome Measures

AU - Chan, Raymond Javan

AU - Gordon, Louisa G.

PY - 2021/3

Y1 - 2021/3

N2 - “Financial toxicity” (FT) describes both the objective financial burden and subjective financial distress from a cancer diagnosis and its treatment.1,2 Up to 48% of cancer survivors report experiencing financial burden due to direct (eg, out-of-pocket expenses) and indirect (eg, loss of income) costs.3 Financial toxicity exists in all health systems including user-pay, universal, and hybrid settings.3,4 Depending on a patient's individual circumstances, cancer diagnosis and treatments, and coping strategies,3 this burden may cause significant financial distress, reduced adherence with treatment, and delayed or forgone treatment, which lead to poorer health outcomes.2,3,5 Our systematic review showed a 3-fold increased risk of depression and anxiety in cancer survivors experiencing FT.6 Individuals living in the most socioeconomically disadvantaged areas are at a greater risk of FT related to cancer care.7

AB - “Financial toxicity” (FT) describes both the objective financial burden and subjective financial distress from a cancer diagnosis and its treatment.1,2 Up to 48% of cancer survivors report experiencing financial burden due to direct (eg, out-of-pocket expenses) and indirect (eg, loss of income) costs.3 Financial toxicity exists in all health systems including user-pay, universal, and hybrid settings.3,4 Depending on a patient's individual circumstances, cancer diagnosis and treatments, and coping strategies,3 this burden may cause significant financial distress, reduced adherence with treatment, and delayed or forgone treatment, which lead to poorer health outcomes.2,3,5 Our systematic review showed a 3-fold increased risk of depression and anxiety in cancer survivors experiencing FT.6 Individuals living in the most socioeconomically disadvantaged areas are at a greater risk of FT related to cancer care.7

KW - Financial Toxicity

KW - Clinical Care

KW - Outcome Measures

UR - http://www.scopus.com/inward/record.url?scp=85101428878&partnerID=8YFLogxK

U2 - 10.1097/NCC.0000000000000926

DO - 10.1097/NCC.0000000000000926

M3 - Editorial

C2 - 33587491

AN - SCOPUS:85101428878

SN - 0162-220X

VL - 44

SP - 87

EP - 88

JO - Cancer nursing

JF - Cancer nursing

IS - 2

ER -

Screening for Financial Toxicity in Clinical Care With Finance-Related Outcome Measures

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this